Work

Phase II trial of the CDK4 inhibitor PD0332991 in CDK4-amplified liposarcoma.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.10002

Authors: Mark Andrew Dickson, Mary Louise Keohan, William D. Tap, Cristina Antonescu, Jonathan Landa, Li-Xuan Qin, Eric Gerard Dohrenwend, Dustin Rathbone, Yelena Ustoyev, Mercedes M Condy, Samuel Singer, Gary K. Schwartz

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2602406713

Cites:

Cited by: 8

Related to: 10